Aaron Newman Bio

Aaron is a Principal at Brighton Park Capital focusing on investments in the healthcare and life sciences sectors. He is currently a Board Observer for BPC's investments in Indegene and Xsolis. Prior to joining BPC in May of 2020, Aaron was an Associate at Summit Partners, a Boston-based growth equity firm, focusing on investments in healthcare, life sciences, and technology. While at Summit Partners, Aaron was responsible for thematic sourcing and deal execution, which included the firm's investment in eClinical Solutions. Previously, Aaron was an Analyst at Jefferies in their Healthcare Investment Banking Group in New York. Aaron graduated from Colgate University with a BA in Physics.